Target intelligence / Profile preview

Blood lipid profile (LP)

Target
LP
Molecular classification
Clinical biomarker panel, Other
01

Overview

A blood lipid profile is a diagnostic panel of blood tests used to measure the concentrations of specific lipid molecules and lipoproteins in the circulation. It typically encompasses four primary measurements: total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides [StatPearls, NBK482250]. While the profile itself is a clinical phenotype rather than a single molecular target, it serves as the primary endpoint for evaluating metabolic health and cardiovascular risk. Abnormalities in these levels, particularly elevated LDL-C and triglycerides, are central to the pathogenesis of atherosclerosis and coronary heart disease [NIH, NHLBI]. Numerous therapeutic classes, including statins, PCSK9 inhibitors, and fibrates, are designed to modify these lipid fractions by interacting with specific enzymes and receptors involved in lipid metabolism and transport [American Heart Association].

Other names
Lipid panelLipid testCholesterol profileLipidogramFasting lipid profile
02

Mechanism of action

Pharmacological agents modulate the blood lipid profile by targeting specific proteins: statins inhibit HMG-CoA reductase to reduce cholesterol synthesis; PCSK9 inhibitors prevent LDL receptor degradation to increase LDL clearance; fibrates activate PPAR-alpha to lower triglycerides; and ezetimibe inhibits NPC1L1 to block intestinal cholesterol absorption [StatPearls, NBK482250; Mayo Clinic].

03

Biological functions

Lipid transport monitoringMetabolic homeostasis assessmentCholesterol metabolism evaluation
04

Disease associations

Cardiovascular diseaseAtherosclerosisDyslipidemiaHypercholesterolemiaHypertriglyceridemiaMetabolic syndrome
05

Safety considerations

Statin-associated muscle symptoms (SAMS)Elevated liver transaminasesIncreased risk of new-onset type 2 diabetes mellitusPotential for hemorrhagic stroke with very low LDL levels (controversial)Gastrointestinal distress
06

Interacting drugs

Atorvastatin

9 more in the full profile.

07

Biomarkers

Low-density lipoprotein cholesterol (LDL-C)High-density lipoprotein cholesterol (HDL-C)Total cholesterolTriglyceridesNon-HDL cholesterolApolipoprotein B (ApoB)

Beyond the preview

Go deeper on Blood lipid profile (LP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood lipid profile (LP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call